Disclosed herein is a pyrazolotriazolopyrimidine derivative or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof useful as A2A receptor antagonist, and a pharmaceutical composition comprising the same. Also disclosed herein is a method of treating cancer using the pyrazolotriazolopyrimidine derivative or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof as A2A receptor antagonist.
本文揭示了一种
吡唑三唑
吡嘧啶衍
生物或其立体异构体,或其药学上可接受的盐,可用作A2A受体拮抗剂,以及包含该物质的药物组合物。本文还揭示了一种使用该
吡唑三唑
吡嘧啶衍
生物或其立体异构体,或其药学上可接受的盐作为A2A受体拮抗剂治疗癌症的方法。